Ibuprofen
- Generic Name
- Ibuprofen
- Brand Names
- Addaprin, Advil, Advil Cold and Sinus, Advil Congestion Relief, Advil PM, Advil Sinus Congestion and Pain, Alivio, Caldolor, Cedaprin, Children's Ibuprofen, Diphen, Duexis, Ibu, Ibutab, Junior Strength Motrin, Motrin, Motrin PM, Neoprofen, Nuprin, Pedea, Proprinal, Reprexain, Sudafed PE Head Congestion Plus Pain, Vicoprofen, Wal-profen Congestion Relief and Pain, Ibuprofen Gen.Orph
- Drug Type
- Small Molecule
- Chemical Formula
- C13H18O2
- CAS Number
- 15687-27-1
- Unique Ingredient Identifier
- WK2XYI10QM
- Background
Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) derived from propionic acid and it is considered the first of the propionics. The formula of ibuprofen is 2-(4-isobutylphenyl) propionic acid and its initial development was in 1960 while researching for a safer alternative for aspirin. Ibuprofen was finally patented in 1961 and this drug was first ...
- Indication
Ibuprofen is the most commonly used and prescribed NSAID. It is a very common over-the-counter medication widely used as an analgesic, anti-inflammatory and antipyretic.
...
- Associated Conditions
- Acute Pain, Ankylosing Spondylitis (AS), Common Cold, Cystic Fibrosis (CF), Fever, Gastric Ulcer, Gout, Headache, Insomnia, Juvenile Idiopathic Arthritis (JIA), Menstrual Distress (Dysmenorrhea), Migraine, Mild pain, Nasal Congestion, Osteoarthritis (OA), Pain, Pain, Inflammatory, Patent Ductus Arteriosus (PDA), Pericarditis, Primary Dysmenorrhoea, Rheumatoid Arthritis, Severe Pain, Sinus pressure, Mild to moderate pain, Minor aches and pains, Moderate Pain
- Associated Therapies
- -
Treatment of Fever Due to Malaria With Ibuprofen
- Conditions
- First Posted Date
- 2005-09-14
- Last Posted Date
- 2005-09-21
- Lead Sponsor
- Albert Schweitzer Hospital
- Target Recruit Count
- 50
- Registration Number
- NCT00167713
- Locations
- 🇬🇦
Medical research Unit, Lambaréné, Lambaréné, Moyen Ogooué, Gabon
Prevention of Ectopic Bone Related Pain and Disability After Hip Replacement Surgery With Peri-Operative Ibuprofen
- Conditions
- First Posted Date
- 2005-09-05
- Last Posted Date
- 2006-11-29
- Lead Sponsor
- The George Institute
- Target Recruit Count
- 1000
- Registration Number
- NCT00145730
Ketorolac Versus Ibuprofen to Treat Painful Episodes of Sickle Cell Disease
- Conditions
- Interventions
- First Posted Date
- 2005-06-22
- Last Posted Date
- 2020-10-08
- Lead Sponsor
- Children's Hospital Medical Center, Cincinnati
- Target Recruit Count
- 10
- Registration Number
- NCT00115336
- Locations
- 🇺🇸
University of Texas Southwestern Medical Center, Dallas, Texas, United States
Pain Relief - Tramadol Versus Ibuprofen
- Conditions
- First Posted Date
- 2005-05-17
- Last Posted Date
- 2005-11-10
- Lead Sponsor
- Royal Liverpool University Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT00111046
- Locations
- 🇬🇧
Royal Liverpool University Hospital, Liverpool, Merseyside, United Kingdom
The Effect of Short-Term Statins and NSAIDs on Levels of Beta-Amyloid, a Protein Associated With Alzheimer's Disease
- Conditions
- First Posted Date
- 2002-09-27
- Last Posted Date
- 2008-03-04
- Lead Sponsor
- National Institute of Mental Health (NIMH)
- Target Recruit Count
- 50
- Registration Number
- NCT00046358
- Locations
- 🇺🇸
National Institute of Mental Health (NIMH), Bethesda, Maryland, United States
The Effects of AZT and Ibuprofen on HIV-Infected Patients With Hemophilia
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- University of Pittsburgh
- Registration Number
- NCT00002276
- Locations
- 🇺🇸
Hemophilia Ctr of Western PA / Univ of Pittsburgh, Pittsburgh, Pennsylvania, United States
Ibuprofen in Sepsis Study
- Conditions
- First Posted Date
- 1999-10-28
- Last Posted Date
- 2016-02-01
- Lead Sponsor
- Vanderbilt University
- Registration Number
- NCT00000574
Study of Ibuprofen to Preserve Lung Function in Patients With Cystic Fibrosis
- Conditions
- First Posted Date
- 1999-10-19
- Last Posted Date
- 2015-03-25
- Lead Sponsor
- FDA Office of Orphan Products Development
- Target Recruit Count
- 75
- Registration Number
- NCT00004440
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.